Emerging evidence for the neuroprotective role of α-synuclein

Experimental Neurology

Volumn 200, Issue 1, 2006, Pages 1-7

  Lee, Hyoung gon ^a   Zhu, Xiongwei ^a   Takeda, Atsushi ^b   Perry, George ^a,c   Smith, Mark A ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c University of San Antonio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN;

ALZHEIMER DISEASE; ARTICLE; DEGENERATIVE DISEASE; HUMAN; HUNTINGTON CHOREA; LEWY BODY; NEUROFIBRILLARY TANGLE; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL;

EID: 33746064033     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2006.04.024     Document Type: Note

References (112)

1. Arrasate M., Mitra S., Schweitzer E.S., Segal M.R., and Finkbeiner S. Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 431 (2004) 805-810
2. Atwood C.S., Moir R.D., Huang X., Scarpa R.C., Bacarra N.M., Romano D.M., Hartshorn M.A., Tanzi R.E., and Bush A.I. Dramatic aggregation of Alzheimer abeta by Cu(II) is induced by conditions representing physiological acidosis. J. Biol. Chem. 273 (1998) 12817-12826
3. Atwood C.S., Perry G., and Smith M.A. Cerebral hemorrhage and amyloid-beta. Science 299 (2003) 1014 (author reply 1014)
4. Behl C., Davis J., Cole G.M., and Schubert D. Vitamin E protects nerve cells from amyloid beta protein toxicity. Biochem. Biophys. Res. Commun. 186 (1992) 944-950
5. Betarbet R., Sherer T.B., MacKenzie G., Garcia-Osuna M., Panov A.V., and Greenamyre J.T. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat. Neurosci. 3 (2000) 1301-1306
6. Blumbergs P.C., Scott G., Manavis J., Wainwright H., Simpson D.A., and McLean A.J. Topography of axonal injury as defined by amyloid precursor protein and the sector scoring method in mild and severe closed head injury. J. Neurotrauma 12 (1995) 565-572
7. Brugg B., Dubreuil Y.L., Huber G., Wollman E.E., Delhaye-Bouchaud N., and Mariani J. Inflammatory processes induce beta-amyloid precursor protein changes in mouse brain. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 3032-3035
8. Burdick D., Soreghan B., Kwon M., Kosmoski J., Knauer M., Henschen A., Yates J., Cotman C., and Glabe C. Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs. J. Biol. Chem. 267 (1992) 546-554
9. Buxbaum J.D., Oishi M., Chen H.I., Pinkas-Kramarski R., Jaffe E.A., Gandy S.E., and Greengard P. Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer beta/A4 amyloid protein precursor. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 10075-10078
10. Buxbaum J.D., Liu K.N., Luo Y., Slack J.L., Stocking K.L., Peschon J.J., Johnson R.S., Castner B.J., Cerretti D.P., and Black R.A. Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloid protein precursor. J. Biol. Chem. 273 (1998) 27765-27767
11. Caporaso G.L., Gandy S.E., Buxbaum J.D., Ramabhadran T.V., and Greengard P. Protein phosphorylation regulates secretion of Alzheimer beta/A4 amyloid precursor protein. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 3055-3059
12. Cash A.D., Aliev G., Siedlak S.L., Nunomura A., Fujioka H., Zhu X., Raina A.K., Vinters H.V., Tabaton M., Johnson A.B., Paula-Barbosa M., Avila J., Jones P.K., Castellani R.J., Smith M.A., and Perry G. Microtubule reduction in Alzheimer's disease and aging is independent of tau filament formation. Am. J. Pathol. 162 (2003) 1623-1627
13. Choi P., Golts N., Snyder H., Chong M., Petrucelli L., Hardy J., Sparkman D., Cochran E., Lee J.M., and Wolozin B. Co-association of parkin and alpha-synuclein. NeuroReport 12 (2001) 2839-2843
14. Ciallella J.R., Rangnekar V.V., and McGillis J.P. Heat shock alters Alzheimer's beta amyloid precursor protein expression in human endothelial cells. J. Neurosci. Res. 37 (1994) 769-776
15. Citron M., Teplow D.B., and Selkoe D.J. Generation of amyloid beta protein from its precursor is sequence specific. Neuron 14 (1995) 661-670
16. Davies L., Wolska B., Hilbich C., Multhaup G., Martins R., Simms G., Beyreuther K., and Masters C.L. A4 amyloid protein deposition and the diagnosis of Alzheimer's disease: prevalence in aged brains determined by immunocytochemistry compared with conventional neuropathologic techniques. Neurology 38 (1988) 1688-1693
17. Di Patre P.L., Read S.L., Cummings J.L., Tomiyasu U., Vartavarian L.M., Secor D.L., and Vinters H.V. Progression of clinical deterioration and pathological changes in patients with Alzheimer disease evaluated at biopsy and autopsy. Arch. Neurol. 56 (1999) 1254-1261
18. Drake J., Link C.D., and Butterfield D.A. Oxidative stress precedes fibrillar deposition of Alzheimer's disease amyloid beta-peptide (1-42) in a transgenic Caenorhabditis elegans model. Neurobiol. Aging 24 (2003) 415-420
19. Frederikse P.H., Garland D., Zigler Jr. J.S., and Piatigorsky J. Oxidative stress increases production of beta-amyloid precursor protein and beta-amyloid (Abeta) in mammalian lenses, and Abeta has toxic effects on lens epithelial cells. J. Biol. Chem. 271 (1996) 10169-10174
20. Gabuzda D., Busciglio J., Chen L.B., Matsudaira P., and Yankner B.A. Inhibition of energy metabolism alters the processing of amyloid precursor protein and induces a potentially amyloidogenic derivative. J. Biol. Chem. 269 (1994) 13623-13628
21. Geddes J.F., Vowles G.H., Beer T.W., and Ellison D.W. The diagnosis of diffuse axonal injury: implications for forensic practice. Neuropathol. Appl. Neurobiol. 23 (1997) 339-347
22. Gentleman S.M., Nash M.J., Sweeting C.J., Graham D.I., and Roberts G.W. Beta-amyloid precursor protein (beta APP) as a marker for axonal injury after head injury. Neurosci. Lett. 160 (1993) 139-144
23. Glenner G.G., and Wong C.W. Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein. Biochem. Biophys. Res. Commun. 122 (1984) 1131-1135
24. Glenner G.G., and Wong C.W. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120 (1984) 885-890
25. Goldgaber D., Harris H.W., Hla T., Maciag T., Donnelly R.J., Jacobsen J.S., Vitek M.P., and Gajdusek D.C. Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells. Proc. Natl. Acad. Sci. U. S. A. 86 (1989) 7606-7610
26. Gomez-Ramos A., Diaz-Nido J., Smith M.A., Perry G., and Avila J. Effect of the lipid peroxidation product acrolein on tau phosphorylation in neural cells. J. Neurosci. Res. 71 (2003) 863-870
27. Haass C., Schlossmacher M.G., Hung A.Y., Vigo-Pelfrey C., Mellon A., Ostaszewski B.L., Lieberburg I., Koo E.H., Schenk D., Teplow D.B., and Selkoe D.J. Amyloid beta-peptide is produced by cultured cells during normal metabolism. Nature 359 (1992) 322-325
28. Hall E.D., Oostveen J.A., Dunn E., and Carter D.B. Increased amyloid protein precursor and apolipoprotein E immunoreactivity in the selectively vulnerable hippocampus following transient forebrain ischemia in gerbils. Exp. Neurol. 135 (1995) 17-27
29. Hardy J.A., and Higgins G.A. Alzheimer's disease: the amyloid cascade hypothesis. Science 256 (1992) 184-185
30. Hardy J., and Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297 (2002) 353-356
31. Hasegawa T., Matsuzaki M., Takeda A., Kikuchi A., Akita H., Perry G., Smith M.A., and Itoyama Y. Accelerated alpha-synuclein aggregation after differentiation of SH-SY5Y neuroblastoma cells. Brain Res. 1013 (2004) 51-59
32. Hashimoto M., Hsu L.J., Rockenstein E., Takenouchi T., Mallory M., and Masliah E. alpha-Synuclein protects against oxidative stress via inactivation of the c-Jun N-terminal kinase stress-signaling pathway in neuronal cells. J. Biol. Chem. 277 (2002) 11465-11472
33. Higgins G.A., Oyler G.A., Neve R.L., Chen K.S., and Gage F.H. Altered levels of amyloid protein precursor transcripts in the basal forebrain of behaviorally impaired aged rats. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 3032-3036
34. Hirai K., Aliev G., Nunomura A., Fujioka H., Russell R.L., Atwood C.S., Johnson A.B., Kress Y., Vinters H.V., Tabaton M., Shimohama S., Cash A.D., Siedlak S.L., Harris P.L., Jones P.K., Petersen R.B., Perry G., and Smith M.A. Mitochondrial abnormalities in Alzheimer's disease. J. Neurosci. 21 (2001) 3017-3023
35. Hou L., Kang I., Marchant R.E., and Zagorski M.G. Methionine 35 oxidation reduces fibril assembly of the amyloid abeta-(1-42) peptide of Alzheimer's disease. J. Biol. Chem. 277 (2002) 40173-40176
36. Jarrett J.T., and Lansbury Jr. P.T. Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie?. Cell 73 (1993) 1055-1058
37. Jendroska K., Poewe W., Daniel S.E., Pluess J., Iwerssen-Schmidt H., Paulsen J., Barthel S., Schelosky L., Cervos-Navarro J., and DeArmond S.J. Ischemic stress induces deposition of amyloid beta immunoreactivity in human brain. Acta Neuropathol. (Berl.) 90 (1995) 461-466
38. Joseph J., Shukitt-Hale B., Denisova N.A., Martin A., Perry G., and Smith M.A. Copernicus revisited: amyloid beta in Alzheimer's disease. Neurobiol. Aging 22 (2001) 131-146
39. Kaltschmidt B., Uherek M., Wellmann H., Volk B., and Kaltschmidt C. Inhibition of NF-kappaB potentiates amyloid beta-mediated neuronal apoptosis. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 9409-9414
40. Kang J., Lemaire H.G., Unterbeck A., Salbaum J.M., Masters C.L., Grzeschik K.H., Multhaup G., Beyreuther K., and Muller-Hill B. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325 (1987) 733-736
41. Kawarabayashi T., Younkin L.H., Saido T.C., Shoji M., Ashe K.H., and Younkin S.G. Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease. J. Neurosci. 21 (2001) 372-381
42. Kayed R., Head E., Thompson J.L., McIntire T.M., Milton S.C., Cotman C.W., and Glabe C.G. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300 (2003) 486-489
43. Klein W.L., Krafft G.A., and Finch C.E. Targeting small Abeta oligomers: the solution to an Alzheimer's disease conundrum?. Trends Neurosci. 24 (2001) 219-224
44. Koo E.H., Park L., and Selkoe D.J. Amyloid beta-protein as a substrate interacts with extracellular matrix to promote neurite outgrowth. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 4748-4752
45. Kragh-Hansen U., Minchiotti L., Brennan S.O., and Sugita O. Hormone binding to natural mutants of human serum albumin. Eur. J. Biochem. 193 (1990) 169-174
46. Kuentzel S.L., Ali S.M., Altman R.A., Greenberg B.D., and Raub T.J. The Alzheimer beta-amyloid protein precursor/protease nexin-II is cleaved by secretase in a trans-Golgi secretory compartment in human neuroglioma cells. Biochem. J. 295 Pt. 2 (1993) 367-378
47. Lambert M.P., Barlow A.K., Chromy B.A., Edwards C., Freed R., Liosatos M., Morgan T.E., Rozovsky I., Trommer B., Viola K.L., Wals P., Zhang C., Finch C.E., Krafft G.A., and Klein W.L. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 6448-6453
48. Lee M.K., Stirling W., Xu Y., Xu X., Qui D., Mandir A.S., Dawson T.M., Copeland N.G., Jenkins N.A., and Price D.L. Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 -> Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 8968-8973
49. Lee H.G., Casadesus G., Zhu X., Takeda A., Perry G., and Smith M.A. Challenging the amyloid cascade hypothesis: senile plaques and amyloid-beta as protective adaptations to Alzheimer disease. Ann. N. Y. Acad. Sci. 1019 (2004) 1-4
50. Lee H.G., Castellani R.J., Zhu X., Perry G., and Smith M.A. Amyloid-beta in Alzheimer's disease: the horse or the cart? Pathogenic or protective?. Int. J. Exp. Pathol. 86 (2005) 133-138
51. Lee H.G., Perry G., Moreira P.I., Garrett M.R., Liu Q., Zhu X., Takeda A., Nunomura A., and Smith M.A. Tau phosphorylation in Alzheimer's disease: pathogen or protector?. Trends Mol. Med. 11 (2005) 164-169
52. Luo Y., Sunderland T., Roth G.S., and Wolozin B. Physiological levels of beta-amyloid peptide promote PC12 cell proliferation. Neurosci. Lett. 217 (1996) 125-128
53. Mann D.M., Jones D., South P.W., Snowden J.S., and Neary D. Deposition of amyloid beta protein in non-Alzheimer dementias: evidence for a neuronal origin of parenchymal deposits of beta protein in neurodegenerative disease. Acta Neuropathol. (Berl.) 83 (1992) 415-419
54. Manning-Bog A.B., McCormack A.L., Purisai M.G., Bolin L.M., and Di Monte D.A. Alpha-synuclein overexpression protects against paraquat-induced neurodegeneration. J. Neurosci. 23 (2003) 3095-3099
55. Masliah E., Rockenstein E., Veinbergs I., Mallory M., Hashimoto M., Takeda A., Sagara Y., Sisk A., and Mucke L. Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. Science 287 (2000) 1265-1269
56. Masters C.L., Simms G., Weinman N.A., Multhaup G., McDonald B.L., and Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl. Acad. Sci. U. S. A. 82 (1985) 4245-4249
57. Matsuoka Y., Vila M., Lincoln S., McCormack A., Picciano M., LaFrancois J., Yu X., Dickson D., Langston W.J., McGowan E., Farrer M., Hardy J., Duff K., Przedborski S., and Di Monte D.A. Lack of nigral pathology in transgenic mice expressing human alpha-synuclein driven by the tyrosine hydroxylase promoter. Neurobiol. Dis. 8 (2001) 535-539
58. Matsuzaki M., Hasegawa T., Takeda A., Kikuchi A., Furukawa K., Kato Y., and Itoyama Y. Histochemical features of stress-induced aggregates in alpha-synuclein overexpressing cells. Brain Res. 1004 (2004) 83-90
59. Mattson M.P., and Pedersen W.A. Effects of amyloid precursor protein derivatives and oxidative stress on basal forebrain cholinergic systems in Alzheimer's disease. Int. J. Dev. Neurosci. 16 (1998) 737-753
60. Misonou H., Morishima-Kawashima M., and Ihara Y. Oxidative stress induces intracellular accumulation of amyloid beta-protein (Abeta) in human neuroblastoma cells. Biochemistry 39 (2000) 6951-6959
61. Mouradian M.M. Recent advances in the genetics and pathogenesis of Parkinson disease. Neurology 58 (2002) 179-185
62. Murakami N., Yamaki T., Iwamoto Y., Sakakibara T., Kobori N., Fushiki S., and Ueda S. Experimental brain injury induces expression of amyloid precursor protein, which may be related to neuronal loss in the hippocampus. J. Neurotrauma 15 (1998) 993-1003
63. Neve R.L., and Robakis N.K. Alzheimer's disease: a re-examination of the amyloid hypothesis. Trends Neurosci. 21 (1998) 15-19
64. Nishimoto I., Okamoto T., Matsuura Y., Takahashi S., Okamoto T., Murayama Y., and Ogata E. Alzheimer amyloid protein precursor complexes with brain GTP-binding protein G(o). Nature 362 (1993) 75-79
65. Nordstedt C., Gandy S.E., Alafuzoff I., Caporaso G.L., Iverfeldt K., Grebb J.A., Winblad B., and Greengard P. Alzheimer beta/A4 amyloid precursor protein in human brain: aging-associated increases in holoprotein and in a proteolytic fragment. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 8910-8914
66. Nunomura A., Perry G., Pappolla M.A., Wade R., Hirai K., Chiba S., and Smith M.A. RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease. J. Neurosci. 19 (1999) 1959-1964
67. Nunomura A., Perry G., Pappolla M.A., Friedland R.P., Hirai K., Chiba S., and Smith M.A. Neuronal oxidative stress precedes amyloid-beta deposition in Down syndrome. J. Neuropathol. Exp. Neurol. 59 (2000) 1011-1017
68. Nunomura A., Perry G., Aliev G., Hirai K., Takeda A., Balraj E.K., Jones P.K., Ghanbari H., Wataya T., Shimohama S., Chiba S., Atwood C.S., Petersen R.B., and Smith M.A. Oxidative damage is the earliest event in Alzheimer disease. J. Neuropathol. Exp. Neurol. 60 (2001) 759-767
69. Ostrerova-Golts N., Petrucelli L., Hardy J., Lee J.M., Farer M., and Wolozin B. The A53T alpha-synuclein mutation increases iron-dependent aggregation and toxicity. J. Neurosci. 20 (2000) 6048-6054
70. Panegyres P.K. The effects of excitotoxicity on the expression of the amyloid precursor protein gene in the brain and its modulation by neuroprotective agents. J. Neural. Transm. 105 (1998) 463-478
71. Paola D., Domenicotti C., Nitti M., Vitali A., Borghi R., Cottalasso D., Zaccheo D., Odetti P., Strocchi P., Marinari U.M., Tabaton M., and Pronzato M.A. Oxidative stress induces increase in intracellular amyloid beta-protein production and selective activation of betaI and betaII PKCs in NT2 cells. Biochem. Biophys. Res. Commun. 268 (2000) 642-646
72. Perry G., Nunomura A., Raina A.K., and Smith M.A. Amyloid-beta junkies. Lancet 355 (2000) 757
73. Pike C.J., Walencewicz A.J., Glabe C.G., and Cotman C.W. Aggregation-related toxicity of synthetic beta-amyloid protein in hippocampal cultures. Eur. J. Pharmacol. 207 (1991) 367-368
74. Postuma R.B., He W., Nunan J., Beyreuther K., Masters C.L., Barrow C.J., and Small D.H. Substrate-bound beta-amyloid peptides inhibit cell adhesion and neurite outgrowth in primary neuronal cultures. J. Neurochem. 74 (2000) 1122-1130
75. Pratico D., Uryu K., Leight S., Trojanoswki J.Q., and Lee V.M. Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis. J. Neurosci. 21 (2001) 4183-4187
76. Quilty M.C., King A.E., Gai W.P., Pountney D.L., West A.K., Vickers J.C., and Dickson T.C. Alpha-synuclein is upregulated in neurones in response to chronic oxidative stress and is associated with neuroprotection. Exp. Neurol. (2006) 10.1016/j.expneurol.2005.10.018 (this issue)
77. Rathke-Hartlieb S., Kahle P.J., Neumann M., Ozmen L., Haid S., Okochi M., Haass C., and Schulz J.B. Sensitivity to MPTP is not increased in Parkinson's disease-associated mutant alpha-synuclein transgenic mice. J. Neurochem. 77 (2001) 1181-1184
78. Roberts G.W., Gentleman S.M., Lynch A., Murray L., Landon M., and Graham D.I. Beta amyloid protein deposition in the brain after severe head injury: implications for the pathogenesis of Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 57 (1994) 419-425
79. Robinson S.R., and Bishop G.M. Abeta as a bioflocculant: implications for the amyloid hypothesis of Alzheimer's disease. Neurobiol. Aging 23 (2002) 1051-1072
80. Rottkamp C.A., Raina A.K., Zhu X., Gaier E., Bush A.I., Atwood C.S., Chevion M., Perry G., and Smith M.A. Redox-active iron mediates amyloid-beta toxicity. Free Radical Biol. Med. 30 (2001) 447-450
81. Rottkamp C.A., Atwood C.S., Joseph J.A., Nunomura A., Perry G., and Smith M.A. The state versus amyloid-beta: the trial of the most wanted criminal in Alzheimer disease. Peptides 23 (2002) 1333-1341
82. Selkoe D.J. Translating cell biology into therapeutic advances in Alzheimer's disease. Nature 399 (1999) A23-A31
83. Selkoe D.J. Alzheimer's disease is a synaptic failure. Science 298 (2002) 789-791
84. Shastry B.S. Parkinson disease: etiology, pathogenesis and future of gene therapy. Neurosci. Res. 41 (2001) 5-12
85. Shi J., Xiang Y., and Simpkins J.W. Hypoglycemia enhances the expression of mRNA encoding beta-amyloid precursor protein in rat primary cortical astroglial cells. Brain Res. 772 (1997) 247-251
86. Shi J., Panickar K.S., Yang S.H., Rabbani O., Day A.L., and Simpkins J.W. Estrogen attenuates over-expression of beta-amyloid precursor protein messenger RNA in an animal model of focal ischemia. Brain Res. 810 (1998) 87-92
87. Shoji M., Golde T.E., Ghiso J., Cheung T.T., Estus S., Shaffer L.M., Cai X.D., McKay D.M., Tintner R., Frangione B., and Younkin S. Production of the Alzheimer amyloid beta protein by normal proteolytic processing. Science 258 (1992) 126-129
88. Singh V.K., Cheng J.F., and Leu S.J. Effect of substance P and protein kinase inhibitors on beta-amyloid peptide-induced proliferation of cultured brain cells. Brain Res. 660 (1994) 353-356
89. Sisodia S.S. Secretion of the beta-amyloid precursor protein. Ann. N. Y. Acad. Sci. 674 (1992) 53-57
90. Smith M.A. Alzheimer disease. Int. Rev. Neurobiol. 42 (1998) 1-54
91. Smith M.A., Harris P.L., Sayre L.M., and Perry G. Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 9866-9868
92. Smith M.A., Casadesus G., Joseph J.A., and Perry G. Amyloid-beta and tau serve antioxidant functions in the aging and Alzheimer brain. Free Radical Biol. Med. 33 (2002) 1194-1199
93. Stephenson D.T., Rash K., and Clemens J.A. Amyloid precursor protein accumulates in regions of neurodegeneration following focal cerebral ischemia in the rat. Brain Res. 593 (1992) 128-135
94. Takenouchi T., and Munekata E. Trophic effects of substance P and beta-amyloid peptide on dibutyryl cyclic AMP-differentiated human leukemic (HL-60) cells. Life Sci. 56 (1995) PL479-PL484
95. Topper R., Gehrmann J., Banati R., Schwarz M., Block F., Noth J., and Kreutzberg G.W. Rapid appearance of beta-amyloid precursor protein immunoreactivity in glial cells following excitotoxic brain injury. Acta Neuropathol. (Berl.) 89 (1995) 23-28
96. Urbanc B., Cruz L., Le R., Sanders J., Ashe K.H., Duff K., Stanley H.E., Irizarry M.C., and Hyman B.T. Neurotoxic effects of thioflavin S-positive amyloid deposits in transgenic mice and Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 13990-13995
97. van Gool W.A., Schenk D.B., and Bolhuis P.A. Concentrations of amyloid-beta protein in cerebrospinal fluid increase with age in patients free from neurodegenerative disease. Neurosci. Lett. 172 (1994) 122-124
98. Vila M., Vukosavic S., Jackson-Lewis V., Neystat M., Jakowec M., and Przedborski S. Alpha-synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the parkinsonian toxin MPTP. J. Neurochem. 74 (2000) 721-729
99. Wallace W., Ahlers S.T., Gotlib J., Bragin V., Sugar J., Gluck R., Shea P.A., Davis K.L., and Haroutunian V. Amyloid precursor protein in the cerebral cortex is rapidly and persistently induced by loss of subcortical innervation. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 8712-8716
100. Wataya T., Nunomura A., Smith M.A., Siedlak S.L., Harris P.L., Shimohama S., Szweda L.I., Kaminski M.A., Avila J., Price D.L., Cleveland D.W., Sayre L.M., and Perry G. High molecular weight neurofilament proteins are physiological substrates of adduction by the lipid peroxidation product hydroxynonenal. J. Biol. Chem. 277 (2002) 4644-4648
101. Whitson J.S., Selkoe D.J., and Cotman C.W. Amyloid beta protein enhances the survival of hippocampal neurons in vitro. Science 243 (1989) 1488-1490
102. Whitson J.S., Glabe C.G., Shintani E., Abcar A., and Cotman C.W. Beta-amyloid protein promotes neuritic branching in hippocampal cultures. Neurosci. Lett. 110 (1990) 319-324
103. Xiong Y., Gu Q., Peterson P.L., Muizelaar J.P., and Lee C.P. Mitochondrial dysfunction and calcium perturbation induced by traumatic brain injury. J. Neurotrauma 14 (1997) 23-34
104. Xu J., Kao S.Y., Lee F.J., Song W., Jin L.W., and Yankner B.A. Dopamine-dependent neurotoxicity of alpha-synuclein: a mechanism for selective neurodegeneration in Parkinson disease. Nat. Med. 8 (2002) 600-606
105. Yan S.D., Chen X., Schmidt A.M., Brett J., Godman G., Zou Y.S., Scott C.W., Caputo C., Frappier T., and Smith M.A. Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 7787-7791
106. Yan S.D., Yan S.F., Chen X., Fu J., Chen M., Kuppusamy P., Smith M.A., Perry G., Godman G.C., Nawroth P., et al. Non-enzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid beta-peptide. Nat. Med. 1 (1995) 693-699
107. Yankner B.A., Duffy L.K., and Kirschner D.A. Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. Science 250 (1990) 279-282
108. Yokota M., Saido T.C., Tani E., Yamaura I., and Minami N. Cytotoxic fragment of amyloid precursor protein accumulates in hippocampus after global forebrain ischemia. J. Cereb. Blood Flow Metab. 16 (1996) 1219-1223
109. Zhu X., Rottkamp C.A., Boux H., Takeda A., Perry G., and Smith M.A. Activation of p38 kinase links tau phosphorylation, oxidative stress, and cell cycle-related events in Alzheimer disease. J. Neuropathol. Exp. Neurol. 59 (2000) 880-888
110. Zhu X., Castellani R.J., Takeda A., Nunomura A., Atwood C.S., Perry G., and Smith M.A. Differential activation of neuronal ERK, JNK/SAPK and p38 in Alzheimer disease: the 'two hit' hypothesis. Mech. Ageing Dev. 123 (2001) 39-46
111. Zhu X., Raina A.K., Rottkamp C.A., Aliev G., Perry G., Boux H., and Smith M.A. Activation and redistribution of c-jun N-terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease. J. Neurochem. 76 (2001) 435-441
112. Zou K., Gong J.S., Yanagisawa K., and Michikawa M. A novel function of monomeric amyloid beta-protein serving as an antioxidant molecule against metal-induced oxidative damage. J. Neurosci. 22 (2002) 4833-4841